A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function

The Journal of Clinical Investigation
X FengS L Teitelbaum

Abstract

Osteoclastic bone resorption requires cell-matrix contact, an event mediated by the alpha v beta 3 integrin. The structural components of the integrin that mediate osteoclast function are, however, not in hand. To address this issue, we generated mice lacking the beta 3 integrin gene, which have dysfunctional osteoclasts. Here, we show the full rescue of beta 3(-/-) osteoclast function following expression of a full-length beta 3 integrin. In contrast, truncated beta 3, lacking a cytoplasmic domain (h beta 3c), is completely ineffective in restoring function to beta 3(-/-) osteoclasts. To identify the components of the beta 3 cytoplasmic domain regulating osteoclast function, we generated six point mutants known, in other circumstances, to mediate beta integrin signaling. Of the six, only the S(752)P substitution, which also characterizes a form of the human bleeding disorder Glanzmann's thrombasthenia, fails to rescue beta 3(-/-) osteoclasts or restore ligand-activated signaling in the form of c-src activation. Interestingly, the double mutation Y(747)F/Y(759)F, which disrupts platelet function, does not affect the osteoclast. Thus similarities and distinctions exist in the mechanisms by which the beta 3 integrin regulates pla...Continue Reading

References

Apr 14, 1995·The Journal of Biological Chemistry·T E O'TooleB M Culley
Mar 22, 1996·The Journal of Biological Chemistry·P E HughesM H Ginsberg
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·D S OryR C Mulligan
Dec 24, 1997·Matrix Biology : Journal of the International Society for Matrix Biology·K M Yamada
Jun 6, 1998·The Journal of Biological Chemistry·I NakamuraT Suda
Jun 5, 1998·The Journal of Biological Chemistry·A L JenkinsD R Phillips
Jan 23, 1999·The Journal of Clinical Investigation·K M Hodivala-DilkeR O Hynes
Feb 23, 2000·The Journal of Clinical Investigation·K P McHughS L Teitelbaum

❮ Previous
Next ❯

Citations

May 13, 2006·Journal of Bioenergetics and Biomembranes·L Shannon HollidayJian Zuo
Sep 5, 2006·Reviews in Endocrine & Metabolic Disorders·Angela Bruzzaniti, Roland Baron
Feb 24, 2009·Nature Medicine·Nikolay L MalininTatiana V Byzova
Feb 16, 2005·Nature Medicine·Roberta FaccioWojciech Swat
Aug 5, 2006·The Journal of Biological Chemistry·Taixing CuiYuqing E Chen
Sep 23, 2008·The Journal of Biological Chemistry·Annette M GonzalezJonathan C R Jones
Mar 5, 2009·The Journal of Biological Chemistry·Jianzhong LiuXu Feng
Dec 7, 2011·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jing ChengXu Feng
May 6, 2005·Molecular Biology of the Cell·Angela BruzzanitiRoland Baron
Apr 14, 2006·Molecular Biology of the Cell·Shandiz TehraniJohn A Cooper
May 23, 2012·Molecular and Cellular Biology·Takashi IzawaSteven L Teitelbaum
Dec 12, 2012·Molecular and Cellular Biology·Wei ZouSteven L Teitelbaum
Nov 28, 2007·Annual Review of Pathology·Deborah V Novack, Steven L Teitelbaum
Mar 6, 2003·The Journal of Clinical Investigation·Roberta FaccioSteven L Teitelbaum
Nov 3, 2011·PloS One·Romain DacquinIrma Machuca-Gayet
Nov 10, 2012·PloS One·Ayako MochizukiRyutaro Kamijo
Nov 1, 2003·Proceedings of the National Academy of Sciences of the United States of America·Elena G Arias-SalgadoSanford J Shattil
Nov 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Suzanne J BakewellKatherine N Weilbaecher
May 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sherry WengClay F Semenkovich
Oct 21, 2014·The Journal of Clinical Investigation·Susan LiBaohong Zhao
Aug 24, 2005·The Journal of Cell Biology·Elena Garcia Arias-SalgadoSanford J Shattil
Apr 16, 2003·The Journal of Cell Biology·Gotz von WichertMichael P Sheetz
Apr 19, 2005·Expert Opinion on Investigational Drugs·Andrew Grey, Ian R Reid
Sep 19, 2007·Expert Opinion on Emerging Drugs·Andrew Grey
Jul 16, 2004·The Journal of Clinical Investigation·Michael W-H WangF Patrick Ross
Nov 26, 2002·Biochemical and Biophysical Research Communications·Svetlana DolgilevichLi Sun
Jul 12, 2005·Trends in Cell Biology·Sanford J Shattil
Jan 27, 2007·The American Journal of Pathology·Steven L Teitelbaum
Apr 20, 2006·The Journal of Steroid Biochemistry and Molecular Biology·D SaintierM E Cohen-Solal

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
scanning electron microscopy
light microscopy
immunoprecipitation
flow cytometry

Software Mentioned

OsteoMeasure

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.